Compare RYAM & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | NPCE |
|---|---|---|
| Founded | 1926 | 1997 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.8M | 432.3M |
| IPO Year | 2014 | 2021 |
| Metric | RYAM | NPCE |
|---|---|---|
| Price | $10.06 | $15.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $14.00 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 746.9K | 166.5K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,466,397,000.00 | $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | $8.22 | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $3.35 | $7.56 |
| 52 Week High | $11.85 | $18.97 |
| Indicator | RYAM | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 63.67 |
| Support Level | $6.91 | $15.25 |
| Resistance Level | $11.62 | $15.71 |
| Average True Range (ATR) | 0.53 | 0.66 |
| MACD | -0.13 | 0.22 |
| Stochastic Oscillator | 42.53 | 95.00 |
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.